Detalhe da pesquisa
1.
Tafenoquine versus Primaquine to Prevent Relapse of Plasmodium vivax Malaria.
N Engl J Med
; 380(3): 229-241, 2019 01 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-30650326
2.
Single-Dose Tafenoquine to Prevent Relapse of Plasmodium vivax Malaria.
N Engl J Med
; 380(3): 215-228, 2019 01 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-30650322
3.
Pharmacokinetic Interactions between Tafenoquine and Dihydroartemisinin-Piperaquine or Artemether-Lumefantrine in Healthy Adult Subjects.
Antimicrob Agents Chemother
; 60(12): 7321-7332, 2016 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-27697758
4.
Modeling study of the effect of placebo and medical therapy on storage and voiding symptoms, nocturia, and quality of life in men with prostate enlargement at risk for progression.
Prostate Cancer Prostatic Dis
; 2023 Oct 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-37794168
5.
Tafenoquine exposure assessment, safety, and relapse prevention efficacy in children with Plasmodium vivax malaria: open-label, single-arm, non-comparative, multicentre, pharmacokinetic bridging, phase 2 trial.
Lancet Child Adolesc Health
; 6(2): 86-95, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34871570
6.
Adjusting for covariates in non-inferiority studies with margins defined as risk differences.
Pharm Stat
; 10(5): 461-6, 2011.
Artigo
em Inglês
| MEDLINE | ID: mdl-21956950
7.
Randomized Placebo-Controlled Trial Evaluating the Ophthalmic Safety of Single-Dose Tafenoquine in Healthy Volunteers.
Drug Saf
; 42(9): 1103-1114, 2019 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-31187437
8.
Application of the Stable Isotope Label Approach in Clinical Development-Supporting Dissolution Specifications for a Commercial Tablet Product with Tafenoquine, a Long Half-life Compound.
AAPS J
; 20(4): 74, 2018 06 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-29869298
9.
A randomized, double-blind, active-control trial to evaluate the efficacy and safety of a three day course of tafenoquine monotherapy for the treatment of Plasmodium vivax malaria.
PLoS One
; 12(11): e0187376, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-29121061
10.
Hemolytic Potential of Tafenoquine in Female Volunteers Heterozygous for Glucose-6-Phosphate Dehydrogenase (G6PD) Deficiency (G6PD Mahidol Variant) versus G6PD-Normal Volunteers.
Am J Trop Med Hyg
; 97(3): 702-711, 2017 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-28749773
11.
An early pregnancy HbA1c ≥5.9% (41 mmol/mol) is optimal for detecting diabetes and identifies women at increased risk of adverse pregnancy outcomes.
Diabetes Care
; 37(11): 2953-9, 2014 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-25190675
12.
Tafenoquine at therapeutic concentrations does not prolong Fridericia-corrected QT interval in healthy subjects.
J Clin Pharmacol
; 54(9): 995-1005, 2014 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-24700490
13.
Pharmacokinetics of oral sitamaquine taken with or without food and safety and efficacy for treatment of visceral leishmaniais: a randomized study in Bihar, India.
Am J Trop Med Hyg
; 84(6): 892-900, 2011 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-21633025
14.
Functional outcome after total knee arthroplasty revision: a meta-analysis.
J Arthroplasty
; 17(8): 967-77, 2002 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-12478505